Regulation of Tumor Angiogenesis by EZH2
Open Access
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 18 (2), 185-197
- https://doi.org/10.1016/j.ccr.2010.06.016
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancerThe Lancet Oncology, 2010
- Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivoBMC Cancer, 2009
- Vasohibin-1 Expression in Endothelium of Tumor Blood Vessels Regulates AngiogenesisThe American Journal of Pathology, 2009
- Dicer, Drosha, and Outcomes in Patients with Ovarian CancerNew England Journal of Medicine, 2008
- Functional significance of VEGFR‐2 on ovarian cancer cellsInternational Journal of Cancer, 2008
- Impact of vessel maturation on antiangiogenic therapy in ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2008
- Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma TherapyClinical Cancer Research, 2006
- Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literatureBritish Journal of Cancer, 2006
- The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3Current Opinion in Genetics & Development, 2004
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990